Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M697Revenue (TTM) $M212Net Margin (%)6.3Altman Z-Score2.6
Enterprise Value $M771EPS (TTM) $0.3Operating Margin %15.0Piotroski F-Score5
P/E(ttm)51.3Beneish M-Score1.3Pre-tax Margin (%)8.0Higher ROA y-yN
Price/Book4.810-y EBITDA Growth Rate %--Quick Ratio3.2Cash flow > EarningsY
Price/Sales3.05-y EBITDA Growth Rate %--Current Ratio3.6Lower Leverage y-yN
Price/Free Cash Flow30.8y-y EBITDA Growth Rate %72.9ROA % (ttm)3.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)11.6Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M45.8ROIC % (ttm)14.5Gross Margin Increase y-yN

Gurus Latest Trades with SCMP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
SCMPJoel Greenblatt 2016-06-30 Sold Out -0.03%$10.09 - $12.42
$ 15.2036%Sold Out0
SCMPJoel Greenblatt 2016-03-31 Reduce-0.06%$9.84 - $17.29
$ 15.2020%Reduce -51.23%284,704
SCMPJoel Greenblatt 2015-12-31 Add0.08%$15.56 - $21.48
$ 15.20-15%Add 273.69%583,716
SCMPJoel Greenblatt 2015-09-30 Reduce-0.03%$16.34 - $28.96
$ 15.20-34%Reduce -53.28%156,205
SCMPJoel Greenblatt 2015-06-30 Add0.03%$14.5 - $21.75
$ 15.20-12%Add 222.92%334,346
SCMPJoel Greenblatt 2015-03-31 Buy 0.01%$13.12 - $18.56
$ 15.20-2%New holding103,538
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SCMP is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

SCMP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Greenleaf PeterCEO 2016-11-29Sell200,000$16.84-13.6view
Getman Daniel PDirector 2016-11-29Sell20,000$16.86-13.7view
Alder MatthiasEVP, Bus. Dev.&Lic, G.C. &Sec. 2016-11-28Sell150,000$16-9.06view
Smith Andrew PCFO 2016-11-15Sell1,766$15.58-6.61view
Smith Andrew PCFO 2015-11-16Buy1,605$17.03-14.56view
Getman Daniel PDirector 2015-08-28Sell30,000$28.14-48.29view
Knapp Thomas JFormer Officer 2015-07-20Sell64,528$23.43-37.9view
Kuno Sachiko10% Owner 2015-03-31Sell1,600,000$143.93view
S&R Technology Holdings, LLC10% Owner 2015-03-31Sell1,186,113$143.93view
Ueno Ryuji10% Owner 2015-03-31Sell1,600,000$143.93view

Quarterly/Annual Reports about SCMP:

News about SCMP:

Articles On GuruFocus.com
NeoPhotonics Delivers Sustained Profitability; Gevo Continues Biofuel Deal Momentum May 08 2015 
Pharmaceutical Stock Picks For March Mar 04 2015 
Weekly CEO Sells Highlight: VeriFone Systems Inc, Northeast Utilities, Sucampo Pharmaceuticals Inc, Jan 26 2014 
Weekly CEO Sells Highlight: Sucampo Pharmaceuticals Inc, Family Dollar Stores Inc, Nike Inc, Hallibu Oct 21 2013 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 08 2011 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 03 2010 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 05 2010 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) May 10 2010 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 06 2009 
Sucampo Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 07 2009 

More From Other Websites
Zacks.com featured highlights: Lancaster Colony, Sucampo Pharmaceuticals, Citrix Systems, VMware and... Dec 08 2016
5 Stocks to Buy for Remarkable Earnings Growth in 2017 Dec 07 2016
The Zacks Analyst Blog Highlights: Health Insurance Innovations, Aegean Marine Petroleum Network,... Dec 07 2016
Sage Therapeutics Stock Up on SAGE-547 Regulatory Update Dec 07 2016
Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study Dec 07 2016
Theravance Stock Up on Fast Track Status for Velusetrag Dec 07 2016
5 Best Small-Cap Stocks for 2017 Dec 06 2016
Is Sucampo Pharmaceuticals, Inc. (SCMP) A Good Stock To Buy? Dec 05 2016
Heat Biologics Stock Falls on Negative Bladder Cancer Data Dec 01 2016
Cytori Scleroderma Study Two-Year Follow-Up Data Published Nov 30 2016
PhaseRx Soars on Orphan Drug Status for Rare Liver Disease Nov 30 2016
Zacks.com featured highlights: Chimera Investment, PennyMac Financial Services and Sucampo... Nov 30 2016
Sucampo (SCMP) Worth a Look: Stock Jumps 6.2% in Session Nov 30 2016
Stocks Stay Red As Gold, Oil Prices Rise; Amazon, Building Stocks Weigh Nov 28 2016
Trump-Tied Plays Dip; Under Armour Up On Ticker Switch Nov 28 2016
What You Need To Know For Your Week: Top 3 Earnings On Tap Nov 25 2016
Stocks End Thanksgiving Week With Modest Gains; Oil Slumps 3% Nov 25 2016
Looking for a Growth Stock? Why it is Time to Focus on Sucampo Pharmaceuticals (SCMP) Nov 25 2016
Glaxo Nucala Favorable in Rare Vasculitis Disease Study Nov 24 2016
Why Sucampo Pharmaceuticals (SCMP) Could Be Positioned for a Surge Nov 23 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)